PRIORITY AREAS OF INNOVATION IN CORPORATE STRATEGIES OF MULTINATIONAL PHARMACEUTICAL COMPANIES IN GLOBAL COORDINATES
The purpose of the article is to substantiate global trends in the research and innovation activities of multinational pharmaceutical companies and to identify key directions of transformation in corporate innovation strategies in the context of increased international competition in the global pha...
| Published in: | Economics & Education |
|---|---|
| Main Authors: | Yaroslava Stoliarchuk, Nataliya Moskalyuk, Roman Simonov |
| Format: | Article |
| Language: | English |
| Published: |
Izdevnieciba “Baltija Publishing”
2023-05-01
|
| Subjects: | |
| Online Access: | http://baltijapublishing.lv/index.php/econedu/article/view/2104 |
Similar Items
DOMINANT BUSINESS MODELS IN THE GLOBAL PHARMACEUTICAL INDUSTRY
by: Roman Simonov
Published: (2019-04-01)
by: Roman Simonov
Published: (2019-04-01)
Transformation of Value in Innovative Business Models: The Case of Pharmaceutical Market
by: Denis Klimanov, et al.
Published: (2021-09-01)
by: Denis Klimanov, et al.
Published: (2021-09-01)
FEATURES OF THE INNOVATION PROCESS AT THE UKRAINIAN PHARMACEUTICAL ENTERPRISES
by: O. Chulak
Published: (2013-03-01)
by: O. Chulak
Published: (2013-03-01)
Methodology, strategies, and factors for business innovation in large companies
by: Daniel López Fernández, et al.
Published: (2025-06-01)
by: Daniel López Fernández, et al.
Published: (2025-06-01)
Overcoming internal and external barriers for companies’ innovation development
by: Valeriya Vlasova, et al.
Published: (2024-07-01)
by: Valeriya Vlasova, et al.
Published: (2024-07-01)
Dynamics of Openness in SMEs: A Business Model and Innovation Strategy Perspective
by: Marika Miriam Iivari
Published: (2015-11-01)
by: Marika Miriam Iivari
Published: (2015-11-01)
INNOVATIVE PROCESSES IN THE RUSSIAN PHARMACEUTICAL MARKET
by: E. A. Bykova
Published: (2020-09-01)
by: E. A. Bykova
Published: (2020-09-01)
Effect of centralized volume-based procurement of drugs on business performance of listed pharmaceutical enterprises
by: Zongjun Ke, et al.
Published: (2024-06-01)
by: Zongjun Ke, et al.
Published: (2024-06-01)
The introduction of new technologies and financial support for the innovational pharmaceutical industry in the veterinary medicine sector based on the development of priority areas of the Ukrainian regions
by: I. V. Bushuieva, et al.
Published: (2019-12-01)
by: I. V. Bushuieva, et al.
Published: (2019-12-01)
INNOVATIVE COMPONENT OF THE STRATEGIC SET OF AN ENTERPRISE: DIRECTION OF INTEGRATED REPORTING DEVELOPMENT
by: P. O. Kutsyk, et al.
Published: (2019-06-01)
by: P. O. Kutsyk, et al.
Published: (2019-06-01)
Innovative Business Strategies in the Face of COVID-19: An Approach to Open Innovation of SMEs in the Sonora Region of Mexico
by: Luis Enrique Valdez-Juárez, et al.
Published: (2022-03-01)
by: Luis Enrique Valdez-Juárez, et al.
Published: (2022-03-01)
Innovative Business Strategies in the Face of COVID-19: An Approach to Open Innovation of SMEs in the Sonora Region of Mexico
by: Luis Enrique Valdez-Juárez, et al.
Published: (2022-03-01)
by: Luis Enrique Valdez-Juárez, et al.
Published: (2022-03-01)
Proposal of the evaluation system of preparedness of businesses for implementation of an innovation strategy
by: Viliam Lendel, et al.
Published: (2012-03-01)
by: Viliam Lendel, et al.
Published: (2012-03-01)
Determinants of science-business cooperation in pharmaceutical production – case study
by: Monika Jakubiak, et al.
Published: (2018-01-01)
by: Monika Jakubiak, et al.
Published: (2018-01-01)
New Insights into the Price Dynamics of Prescription Pharmaceuticals in Slovenia over the Period 2001–2014
by: Petra Došenović Bonča, et al.
Published: (2017-11-01)
by: Petra Došenović Bonča, et al.
Published: (2017-11-01)
The Moderating Effects of Dynamic Capability on Radical Innovation and Incremental Innovation Teams in the Global Pharmaceutical Biotechnology Industry
by: Heather Johnson
Published: (2020-04-01)
by: Heather Johnson
Published: (2020-04-01)
Innovative Culture of the Organization and Its Role in the Concept of Corporate Social Responsibility ‒ Czech Republic Case Study
by: Hana Mohelska, et al.
Published: (2017-08-01)
by: Hana Mohelska, et al.
Published: (2017-08-01)
Business Model Innovation Portfolio Strategy for Growth Under Product-Market Configurations
by: Bert Verhoeven, et al.
Published: (2017-07-01)
by: Bert Verhoeven, et al.
Published: (2017-07-01)
THE MAIN DIRECTIONS OF INNOVATION AND INVESTMENT IN THE DEVELOPMENT OF THE ZAKARPAT REGION
by: V. Stegura
Published: (2016-02-01)
by: V. Stegura
Published: (2016-02-01)
Governing pharmaceutical innovations in Africa: Inclusive models for accelerating access to quality medicines
by: Frederick Ahen, et al.
Published: (2018-01-01)
by: Frederick Ahen, et al.
Published: (2018-01-01)
Economic policy uncertainty and corporate innovation-empirical evidence from Chinese pharmaceutical listed companies
by: Zikun Wu, et al.
Published: (2024-12-01)
by: Zikun Wu, et al.
Published: (2024-12-01)
Global Trends in Measuring the Innovative Potential of an Enterprise
by: K. A. Sarsen, et al.
Published: (2023-04-01)
by: K. A. Sarsen, et al.
Published: (2023-04-01)
Driving Sustainability-Oriented Innovation: A Study of Portuguese Industrial Companies’ Business Models
by: Jordana Marques Kneipp, et al.
Published: (2025-10-01)
by: Jordana Marques Kneipp, et al.
Published: (2025-10-01)
Impact of knowledge sharing and innovation on performance of organization: evidence from the pharmaceutical industry of Pakistan
by: Salman Iqbal, et al.
Published: (2025-12-01)
by: Salman Iqbal, et al.
Published: (2025-12-01)
Startup ecosystem of agro-industrial complex
by: A.M. Tkachenko, et al.
Published: (2021-06-01)
by: A.M. Tkachenko, et al.
Published: (2021-06-01)
Pharmaceutical policy and innovation for rare diseases: A narrative review [version 2; peer review: 1 approved, 2 approved with reservations]
by: Marcela Vieira, et al.
Published: (2023-11-01)
by: Marcela Vieira, et al.
Published: (2023-11-01)
The effects of analytical and holistic reasoning perspective on innovation and business performance, a study of state own, FDI and private company in Vietnam
by: Mai Ngoc Khuong, et al.
Published: (2023-12-01)
by: Mai Ngoc Khuong, et al.
Published: (2023-12-01)
The moderation role of entrepreneurial orientation on the influence of innovation on pharmaceutical SMEs' performance
by: Lina Al-Momani, et al.
Published: (2023-06-01)
by: Lina Al-Momani, et al.
Published: (2023-06-01)
Innovative Strategies for Upcycling Agricultural Residues and Their Various Pharmaceutical Applications
by: Ludovic Everard Bejenaru, et al.
Published: (2024-08-01)
by: Ludovic Everard Bejenaru, et al.
Published: (2024-08-01)
INNOVATIVE MECHANISM OF SMALL BUSINESS'S DEVELOPMENT
by: A. Ovchinnikov
Published: (2011-06-01)
by: A. Ovchinnikov
Published: (2011-06-01)
Business Strategies and Competitive Advantage: The Role of Performance and Innovation
by: Ida Farida, et al.
Published: (2022-09-01)
by: Ida Farida, et al.
Published: (2022-09-01)
Business Strategies and Competitive Advantage: The Role of Performance and Innovation
by: Ida Farida, et al.
Published: (2022-09-01)
by: Ida Farida, et al.
Published: (2022-09-01)
Business Process Management as a Strategy to Make Organizational Innovation
by: Baldassarre, Fabrizio, et al.
Published: (2016-11-01)
by: Baldassarre, Fabrizio, et al.
Published: (2016-11-01)
Corporate financialization, financing constraints, and innovation efficiency—Empirical evidence based on listed Chinese pharmaceutical companies
by: Jialin Zhu, et al.
Published: (2023-04-01)
by: Jialin Zhu, et al.
Published: (2023-04-01)
INNOVATIVE TRANSFORMATIONS OF THE VALUE CHAIN OF PHARMACEUTICAL ENTERPRISES
by: Kateryna Kopishynska, et al.
Published: (2021-02-01)
by: Kateryna Kopishynska, et al.
Published: (2021-02-01)
Drivers of business model innovation in family firms: A dataset analysis
by: Angel-Luis Meroño-Cerdan, et al.
Published: (2024-06-01)
by: Angel-Luis Meroño-Cerdan, et al.
Published: (2024-06-01)
EFFECTS OF MANAGERS’ INDIVIDUAL INNOVATIVE BEHAVIOR TENDENCIES AND BUSINESS INNOVATION ON NON-FINANCIAL BUSINESS PERFORMANCE
by: Feridun Duman, et al.
Published: (2019-05-01)
by: Feridun Duman, et al.
Published: (2019-05-01)
Innovative process rational choice grounding in organization
by: S.M. Illiashenko
Published: (2015-06-01)
by: S.M. Illiashenko
Published: (2015-06-01)
How eco-innovative firms were affected by and responded to the unexpected external shock of the COVID-19 pandemic
by: Faraimo Jay Vai, et al.
Published: (2024-06-01)
by: Faraimo Jay Vai, et al.
Published: (2024-06-01)
Impact of innovativeness on business performance in Croatian companies
by: Helena Šlogar
Published: (2020-01-01)
by: Helena Šlogar
Published: (2020-01-01)
Similar Items
-
DOMINANT BUSINESS MODELS IN THE GLOBAL PHARMACEUTICAL INDUSTRY
by: Roman Simonov
Published: (2019-04-01) -
Transformation of Value in Innovative Business Models: The Case of Pharmaceutical Market
by: Denis Klimanov, et al.
Published: (2021-09-01) -
FEATURES OF THE INNOVATION PROCESS AT THE UKRAINIAN PHARMACEUTICAL ENTERPRISES
by: O. Chulak
Published: (2013-03-01) -
Methodology, strategies, and factors for business innovation in large companies
by: Daniel López Fernández, et al.
Published: (2025-06-01) -
Overcoming internal and external barriers for companies’ innovation development
by: Valeriya Vlasova, et al.
Published: (2024-07-01)
